{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:03:28Z","timestamp":1740146608853,"version":"3.37.3"},"reference-count":73,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T00:00:00Z","timestamp":1580256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0228408","type":"journal-article","created":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T13:38:36Z","timestamp":1580305116000},"page":"e0228408","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9191-0178","authenticated-orcid":true,"given":"Natasha","family":"Friend","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline E.","family":"Noll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khatora S.","family":"Opperman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberley C.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krzysztof M.","family":"Mrozik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Vandyke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duncan R.","family":"Hewett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew C. W.","family":"Zannettino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2020,1,29]]},"reference":[{"issue":"12","key":"pone.0228408.ref001","doi-asserted-by":"crossref","first-page":"e538","DOI":"10.1016\/S1470-2045(14)70442-5","article-title":"International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma","volume":"15","author":"SV Rajkumar","year":"2014","journal-title":"The Lancet Oncology"},{"key":"pone.0228408.ref002","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1038\/nrdp.2017.46","article-title":"Multiple myeloma","volume":"3","author":"SK Kumar","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"22","key":"pone.0228408.ref003","doi-asserted-by":"crossref","first-page":"5412","DOI":"10.1182\/blood-2008-12-194241","article-title":"Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study","volume":"113","author":"O Landgren","year":"2009","journal-title":"Blood"},{"issue":"22","key":"pone.0228408.ref004","doi-asserted-by":"crossref","first-page":"5418","DOI":"10.1182\/blood-2008-12-195008","article-title":"A monoclonal gammopathy precedes multiple myeloma in most patients","volume":"113","author":"BM Weiss","year":"2009","journal-title":"Blood"},{"issue":"8","key":"pone.0228408.ref005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"RA Kyle","year":"2002","journal-title":"The New England journal of medicine"},{"issue":"10068","key":"pone.0228408.ref006","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0140-6736(16)31594-X","article-title":"Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial","volume":"389","author":"BG Durie","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"pone.0228408.ref007","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/PPO.0000000000000353","article-title":"Targeted Management Strategies in Multiple Myeloma","volume":"25","author":"SK Kumar","year":"2019","journal-title":"Cancer journal (Sudbury, Mass)"},{"issue":"5","key":"pone.0228408.ref008","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrc3257","article-title":"The genetic architecture of multiple myeloma","volume":"12","author":"GJ Morgan","year":"2012","journal-title":"Nature reviews Cancer"},{"issue":"7339","key":"pone.0228408.ref009","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nature09837","article-title":"Initial genome sequencing and analysis of multiple myeloma","volume":"471","author":"MA Chapman","year":"2011","journal-title":"Nature"},{"key":"pone.0228408.ref010","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1038\/ncomms3997","article-title":"Heterogeneity of genomic evolution and mutational profiles in multiple myeloma","volume":"5","author":"N Bolli","year":"2014","journal-title":"Nature communications"},{"issue":"1","key":"pone.0228408.ref011","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ccr.2013.12.015","article-title":"Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy","volume":"25","author":"JG Lohr","year":"2014","journal-title":"Cancer Cell"},{"issue":"33","key":"pone.0228408.ref012","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1200\/JCO.2014.59.1503","article-title":"Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma","volume":"33","author":"BA Walker","year":"2015","journal-title":"J Clin Oncol"},{"issue":"12","key":"pone.0228408.ref013","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1038\/s41375-018-0037-9","article-title":"Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups","volume":"32","author":"N Bolli","year":"2018","journal-title":"Leukemia"},{"issue":"5","key":"pone.0228408.ref014","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1182\/blood-2012-01-405985","article-title":"Clonal competition with alternating dominance in multiple myeloma","volume":"120","author":"JJ Keats","year":"2012","journal-title":"Blood"},{"issue":"5","key":"pone.0228408.ref015","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1182\/blood-2012-03-412981","article-title":"Intraclonal heterogeneity and distinct molecular mechanisms characterize the development of t(4;14) and t(11;14) myeloma","volume":"120","author":"BA Walker","year":"2012","journal-title":"Blood"},{"issue":"2","key":"pone.0228408.ref016","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/leu.2013.199","article-title":"Intraclonal heterogeneity is a critical early event in the development of myeloma and precedes the development of clinical symptoms","volume":"28","author":"BA Walker","year":"2014","journal-title":"Leukemia"},{"issue":"8","key":"pone.0228408.ref017","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/leu.2014.13","article-title":"Single-cell genetic analysis reveals the composition of initiating clones and phylogenetic patterns of branching and parallel evolution in myeloma","volume":"28","author":"L Melchor","year":"2014","journal-title":"Leukemia"},{"issue":"13","key":"pone.0228408.ref018","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood-2016-06-723007","article-title":"Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma","volume":"128","author":"N Weinhold","year":"2016","journal-title":"Blood"},{"issue":"2","key":"pone.0228408.ref019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41375-018-0206-x","article-title":"Subclonal evolution in disease progression from MGUS\/SMM to multiple myeloma is characterised by clonal stability","volume":"33","author":"AK Dutta","year":"2018","journal-title":"Leukemia"},{"issue":"1","key":"pone.0228408.ref020","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1038\/s41467-018-05058-y","article-title":"Genomic patterns of progression in smoldering multiple myeloma","volume":"9","author":"N Bolli","year":"2018","journal-title":"Nature communications"},{"issue":"12","key":"pone.0228408.ref021","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1038\/leu.2012.128","article-title":"SNP-based mapping arrays reveal high genomic complexity in monoclonal gammopathies, from MGUS to myeloma status","volume":"26","author":"L Lopez-Corral","year":"2012","journal-title":"Leukemia"},{"issue":"2","key":"pone.0228408.ref022","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ygeno.2006.03.021","article-title":"Identification and characterization of RTVP1\/GLIPR1-like genes, a novel p53 target gene cluster","volume":"88","author":"C Ren","year":"2006","journal-title":"Genomics"},{"issue":"7","key":"pone.0228408.ref023","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1210\/er.2008-0032","article-title":"The CAP superfamily: cysteine-rich secretory proteins, antigen 5, and pathogenesis-related 1 proteins\u2014roles in reproduction, cancer, and immune defense","volume":"29","author":"GM Gibbs","year":"2008","journal-title":"Endocrine reviews"},{"issue":"2","key":"pone.0228408.ref024","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jcb.26340","article-title":"TPX2-p53-GLIPR1 regulatory circuitry in cell proliferation, invasion, and tumor growth of bladder cancer","volume":"119","author":"L Yan","year":"2018","journal-title":"Journal of cellular biochemistry"},{"key":"pone.0228408.ref025","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12943-016-0508-4","article-title":"GLI pathogenesis-related 1 functions as a tumor-suppressor in lung cancer","volume":"15","author":"X Sheng","year":"2016","journal-title":"Molecular cancer"},{"issue":"3","key":"pone.0228408.ref026","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1158\/0008-5472.CAN-03-2592","article-title":"RTVP-1, a tumor suppressor inactivated by methylation in prostate cancer","volume":"64","author":"C Ren","year":"2004","journal-title":"Cancer research"},{"issue":"3","key":"pone.0228408.ref027","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3892\/or.2016.4949","article-title":"GLIPR1 inhibits the proliferation and induces the differentiation of cancer-initiating cells by regulating miR-16 in osteosarcoma","volume":"36","author":"J Dong","year":"2016","journal-title":"Oncology reports"},{"issue":"10","key":"pone.0228408.ref028","doi-asserted-by":"crossref","first-page":"3345","DOI":"10.1128\/MCB.22.10.3345-3357.2002","article-title":"mRTVP-1, a novel p53 target gene with proapoptotic activities","volume":"22","author":"C Ren","year":"2002","journal-title":"Molecular and cellular biology"},{"issue":"2","key":"pone.0228408.ref029","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1158\/0008-5472.CAN-07-2931","article-title":"Glioma pathogenesis-related protein 1 exerts tumor suppressor activities through proapoptotic reactive oxygen species-c-Jun-NH2 kinase signaling","volume":"68","author":"L Li","year":"2008","journal-title":"Cancer research"},{"issue":"2","key":"pone.0228408.ref030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1089\/104303403321070793","article-title":"Adenoviral vector-mediated mRTVP-1 gene therapy for prostate cancer","volume":"14","author":"T Satoh","year":"2003","journal-title":"Human gene therapy"},{"issue":"3","key":"pone.0228408.ref031","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.molonc.2012.12.005","article-title":"Glioma pathogenesis-related protein 1 induces prostate cancer cell death through Hsc70-mediated suppression of AURKA and TPX2","volume":"7","author":"L Li","year":"2013","journal-title":"Molecular oncology"},{"issue":"24","key":"pone.0228408.ref032","doi-asserted-by":"crossref","first-page":"7694","DOI":"10.1158\/0008-5472.CAN-11-1714","article-title":"GLIPR1 suppresses prostate cancer development through targeted oncoprotein destruction","volume":"71","author":"L Li","year":"2011","journal-title":"Cancer research"},{"issue":"6","key":"pone.0228408.ref033","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1038\/leu.2011.53","article-title":"Clinical and biological implications of MYC activation: a common difference between MGUS and newly diagnosed multiple myeloma","volume":"25","author":"WJ Chng","year":"2011","journal-title":"Leukemia"},{"key":"pone.0228408.ref034","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1038\/bcj.2014.13","article-title":"Translocations at 8q24 juxtapose MYC with genes that harbor superenhancers resulting in overexpression and poor prognosis in myeloma patients","volume":"4","author":"BA Walker","year":"2014","journal-title":"Blood cancer journal"},{"issue":"8","key":"pone.0228408.ref035","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1038\/leu.2014.70","article-title":"Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma","volume":"28","author":"M Affer","year":"2014","journal-title":"Leukemia"},{"issue":"2","key":"pone.0228408.ref036","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ccr.2008.01.007","article-title":"AID-dependent activation of a MYC transgene induces multiple myeloma in a conditional mouse model of post-germinal center malignancies","volume":"13","author":"M Chesi","year":"2008","journal-title":"Cancer Cell"},{"issue":"8","key":"pone.0228408.ref037","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1182\/blood-2014-04-567909","article-title":"Multiparameter flow cytometry for staging of solitary bone plasmacytoma: new criteria for risk of progression to myeloma","volume":"124","author":"B Paiva","year":"2014","journal-title":"Blood"},{"issue":"8","key":"pone.0228408.ref038","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1182\/blood-2014-04-566521","article-title":"Outcome prediction in plasmacytoma of bone: a risk model utilizing bone marrow flow cytometry and light-chain analysis","volume":"124","author":"QA Hill","year":"2014","journal-title":"Blood"},{"issue":"3","key":"pone.0228408.ref039","first-page":"111","article-title":"Examining Hedgehog pathway genes GLI3, SHH, and PTCH1 and the p53 target GLIPR1\/GLIPR1L1\/GLIPR1L2 gene cluster using fluorescence in situ hybridization uncovers GLIPR1\/GLIPR1L1\/GLIPR1L2 deletion in 9% of patients with multiple myeloma","volume":"36","author":"M Tam","year":"2010","journal-title":"Journal of the Association of Genetic Technologists"},{"issue":"24","key":"pone.0228408.ref040","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1182\/blood-2015-10-673095","article-title":"Phenotypic, transcriptomic, and genomic features of clonal plasma cells in light-chain amyloidosis","volume":"127","author":"B Paiva","year":"2016","journal-title":"Blood"},{"issue":"7","key":"pone.0228408.ref041","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/gcc.20668","article-title":"A SNP microarray and FISH-based procedure to detect allelic imbalances in multiple myeloma: an integrated genomics approach reveals a wide gene dosage effect","volume":"48","author":"L Agnelli","year":"2009","journal-title":"Genes, chromosomes & cancer"},{"issue":"7","key":"pone.0228408.ref042","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1158\/0008-5472.CAN-06-4046","article-title":"Molecular dissection of hyperdiploid multiple myeloma by gene expression profiling","volume":"67","author":"WJ Chng","year":"2007","journal-title":"Cancer research"},{"issue":"6","key":"pone.0228408.ref043","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1182\/blood-2005-11-013458","article-title":"The molecular classification of multiple myeloma","volume":"108","author":"F Zhan","year":"2006","journal-title":"Blood"},{"issue":"13","key":"pone.0228408.ref044","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1182\/blood-2010-12-328252","article-title":"Pharmacogenomics of bortezomib test-dosing identifies hyperexpression of proteasome genes, especially PSMD4, as novel high-risk feature in myeloma treated with Total Therapy 3","volume":"118","author":"JD Shaughnessy","year":"2011","journal-title":"Blood"},{"issue":"7","key":"pone.0228408.ref045","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1359\/jbmr.090210","article-title":"Targeted disruption of the CXCL12\/CXCR4 axis inhibits osteolysis in a murine model of myeloma-associated bone loss. Journal of bone and mineral research : the official journal of the","volume":"24","author":"P Diamond","year":"2009","journal-title":"American Society for Bone and Mineral Research"},{"issue":"4","key":"pone.0228408.ref046","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods (San Diego, Calif)"},{"issue":"7","key":"pone.0228408.ref047","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.neo.2014.07.002","article-title":"SAMSN1 is a tumor suppressor gene in multiple myeloma","volume":"16","author":"JE Noll","year":"2014","journal-title":"Neoplasia (New York, NY)"},{"issue":"4","key":"pone.0228408.ref048","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/mt.2008.6","article-title":"A multicolor panel of novel lentiviral \"gene ontology\" (LeGO) vectors for functional gene analysis","volume":"16","author":"K Weber","year":"2008","journal-title":"Molecular therapy : the journal of the American Society of Gene Therapy"},{"issue":"1","key":"pone.0228408.ref049","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3324\/haematol.2013.090977","article-title":"Myeloma plasma cells alter the bone marrow microenvironment by stimulating the proliferation of mesenchymal stromal cells","volume":"99","author":"JE Noll","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"pone.0228408.ref050","first-page":"593","article-title":"Animal model of human disease. Multiple myeloma","volume":"132","author":"J Radl","year":"1988","journal-title":"The American journal of pathology"},{"issue":"5","key":"pone.0228408.ref051","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1182\/blood.V93.5.1697","article-title":"Ibandronate reduces osteolytic lesions but not tumor burden in a murine model of myeloma bone disease","volume":"93","author":"SL Dallas","year":"1999","journal-title":"Blood"},{"key":"pone.0228408.ref052","first-page":"772","article-title":"Preclinical animal models of multiple myeloma","volume":"5","author":"ST Lwin","year":"2016","journal-title":"Bonekey Rep"},{"issue":"6","key":"pone.0228408.ref053","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ni.3154","article-title":"Transcriptional profiling of mouse B cell terminal differentiation defines a signature for antibody-secreting plasma cells","volume":"16","author":"W Shi","year":"2015","journal-title":"Nat Immunol"},{"issue":"3","key":"pone.0228408.ref054","first-page":"395","article-title":"Idiopathic paraproteinaemia. I. Studies in an animal model\u2014the ageing C57BL\/KaLwRij mouse","volume":"33","author":"J Radl","year":"1978","journal-title":"Clinical and experimental immunology"},{"issue":"6","key":"pone.0228408.ref055","doi-asserted-by":"crossref","first-page":"2966","DOI":"10.4049\/jimmunol.1202493","article-title":"Myeloma is characterized by stage-specific alterations in DNA methylation that occur early during myelomagenesis","volume":"190","author":"CJ Heuck","year":"2013","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"issue":"2","key":"pone.0228408.ref056","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1182\/blood-2010-04-279539","article-title":"Aberrant global methylation patterns affect the molecular pathogenesis and prognosis of multiple myeloma","volume":"117","author":"BA Walker","year":"2011","journal-title":"Blood"},{"issue":"6","key":"pone.0228408.ref057","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1182\/blood-2018-03-840132","article-title":"Identification of novel mutational drivers reveals oncogene dependencies in multiple myeloma","volume":"132","author":"BA Walker","year":"2018","journal-title":"Blood"},{"issue":"2","key":"pone.0228408.ref058","first-page":"609","article-title":"Idiopathic paraproteinemia. II. Transplantation of the paraprotein-producing clone from old to young C57BL\/KaLwRij mice","volume":"122","author":"J Radl","year":"1979","journal-title":"Journal of immunology (Baltimore, Md : 1950)"},{"issue":"5","key":"pone.0228408.ref059","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/1097-0142(19850301)55:5<1030::AID-CNCR2820550518>3.0.CO;2-Y","article-title":"Influence of treatment with APD-bisphosphonate on the bone lesions in the mouse 5T2 multiple myeloma","volume":"55","author":"J Radl","year":"1985","journal-title":"Cancer"},{"issue":"5","key":"pone.0228408.ref060","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/bjc.1987.241","article-title":"The 5T2 mouse multiple myeloma model: characterization of 5T2 cells within the bone marrow","volume":"56","author":"JW Croese","year":"1987","journal-title":"British journal of cancer"},{"issue":"1","key":"pone.0228408.ref061","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1038\/s41598-018-33396-w","article-title":"The genetic landscape of 5T models for multiple myeloma","volume":"8","author":"K Maes","year":"2018","journal-title":"Scientific reports"},{"issue":"2","key":"pone.0228408.ref062","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood-2013-03-487884","article-title":"Global methylation analysis identifies prognostically important epigenetically inactivated tumor suppressor genes in multiple myeloma","volume":"122","author":"MF Kaiser","year":"2013","journal-title":"Blood"},{"key":"pone.0228408.ref063","article-title":"How to Train your T cells: Overcoming Immune Dysfunction in Multiple Myeloma","author":"AD Cohen","year":"2019","journal-title":"Clinical cancer research : an official journal of the American Association for Cancer Research"},{"issue":"9","key":"pone.0228408.ref064","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1158\/0008-5472.CAN-11-2067","article-title":"Bone marrow stromal cells create a permissive microenvironment for myeloma development: a new stromal role for Wnt inhibitor Dkk1","volume":"72","author":"JA Fowler","year":"2012","journal-title":"Cancer research"},{"issue":"4","key":"pone.0228408.ref065","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s10456-017-9571-8","article-title":"Endothelial progenitor cells in multiple myeloma neovascularization: a brick to the wall","volume":"20","author":"MM Tenreiro","year":"2017","journal-title":"Angiogenesis"},{"issue":"7","key":"pone.0228408.ref066","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1007\/s00277-019-03648-4","article-title":"PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression","volume":"98","author":"A Mussetti","year":"2019","journal-title":"Annals of hematology"},{"issue":"1","key":"pone.0228408.ref067","first-page":"76","article-title":"Bone marrow angiogenesis and progression in multiple myeloma","volume":"1","author":"R Ria","year":"2011","journal-title":"American journal of blood research"},{"issue":"11","key":"pone.0228408.ref068","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1038\/nm.4202","article-title":"Microenvironment-dependent growth of preneoplastic and malignant plasma cells in humanized mice","volume":"22","author":"R Das","year":"2016","journal-title":"Nature medicine"},{"issue":"6","key":"pone.0228408.ref069","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S8756-3282(97)00056-2","article-title":"A murine model of human myeloma bone disease","volume":"20","author":"IR Garrett","year":"1997","journal-title":"Bone"},{"issue":"1","key":"pone.0228408.ref070","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/mc.2940140105","article-title":"Effects of genetic background on tumorigenesis in p53-deficient mice","volume":"14","author":"LA Donehower","year":"1995","journal-title":"Molecular carcinogenesis"},{"issue":"9","key":"pone.0228408.ref071","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1128\/MCB.22.9.3174-3177.2002","article-title":"RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice","volume":"22","author":"LK Petiniot","year":"2002","journal-title":"Molecular and cellular biology"},{"issue":"11","key":"pone.0228408.ref072","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1093\/emboj\/16.11.2985","article-title":"Targeted expression of MYCN causes neuroblastoma in transgenic mice","volume":"16","author":"WA Weiss","year":"1997","journal-title":"Embo j"},{"issue":"7","key":"pone.0228408.ref073","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/cdd.2013.35","article-title":"Genetic background and tumour susceptibility in mouse models","volume":"20","author":"J Puccini","year":"2013","journal-title":"Cell death and differentiation"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228408","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,29]],"date-time":"2020-01-29T13:39:14Z","timestamp":1580305154000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0228408"}},"subtitle":[],"editor":[{"given":"Nicola","family":"Amodio","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2020,1,29]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,1,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0228408","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2020,1,29]]}}}